What percent of VRXAW is sold short?

35.6% of Veraxa Biotech (VRXAW) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is VRXAW a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Veraxa Biotech (VRXAW).

VRXAW Short Volume Hit 35.6%

$0.04

-0.01 (-12.53%)

Weekly Expected Move ±41.2%

$0 $0 $0 $0 $0

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $918390 mcap · 13M float · 0.458% daily turnover · Short 44% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Short Volume Summary

2026-10-01

19.4%

Short Ratio

of total volume

48.4%

20-Day Avg

42.9%

50-Day Avg

▼ Falling

5-Day Trend

0.0M

Short Volume

0.0M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	9,500	48,973	19.4%

VRXAW Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet